The Ministry of Health in Fiji has launched an inquiry into potential drug use by healthcare professionals, underscoring concerns about patient safety. Health Minister Dr. Atonio Lalabalavu confirmed the seriousness of these allegations and emphasized established procedures would be followed in handling such cases. Dr. Lalabalavu emphasized that addiction treatment is prioritized before a healthcare professional is reassessed for fitness to return to their duties.
In addressing random drug testing for healthcare workers, Dr. Lalabalavu stated that the matter would require approval from the Ministry of Civil Service. The concerns are echoed by the President of the Fiji Medical Association, Dr. Alipate Vakamocea, who highlighted the risks associated with healthcare professionals under the influence of drugs, stressing potential legal implications of negligence.
Acting Prime Minister and Minister for Finance, Professor Biman Prasad, reaffirmed the government’s zero tolerance toward drug usage among healthcare workers, emphasizing the importance of patient safety, accountability, and trust within Fiji’s healthcare system.
This investigation emerges amid broader discussions on drug testing policies across various sectors in Fiji. There have been recent discussions regarding mandatory drug testing for public servants, including police officers and drivers, highlighting a national focus on combating the drug problem and ensuring public safety.
The government’s approach reflects a commitment to maintaining high standards of integrity and trust within public institutions, emphasizing leadership by example. This proactive stance is expected to bolster public confidence in the healthcare system and foster a safer environment for all citizens.